Abstract Using a structural model, I estimate the value gain from coinsurance when two firms merge. For most mergers, the estimated gains from coinsurance are small, smaller than the counterfactual gains if firms were to merge randomly, suggesting that coinsurance is not the primary motivation for most mergers. Diversifying mergers produce no higher coinsurance than related mergers. Target leverage and relative size predict coinsurance better than cash flow correlation-a common proxy for coinsurance. The cumulative abnormal return around merger announcement increases 0.89% for every 1% estimated value gain from coinsurance, suggesting that stock holders benefit from coinsurance, contrary to a common claim in textbooks.
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